Vector Laboratories’ blog provides a wealth of information on immunohistochemistry (IHC), immunofluorescence (IF), and related life science research topics.
Vector Laboratories will be at NSH 2026 to show how VectaPlex™ advances spatial oncology research. Director of R&D Erika Leonard, Sr. Field Application Scientist Sabrina Mateos, and Lead Technical Support Specialist Anjali Haridasan will represent... Read more
Immuno-oncology research often hinges on the ability to characterize complex biological systems—the tumor microenvironment, effector T cells, immune checkpoints, to name a few. Probing these systems requires tools that reliably capture the spatial biology, perform... Read more
Obesity is a disease with broad causes and effects. The study, diagnosis, and treatment of obesity have implications from the population level down to the individual (but interconnected) biological pathways in each person. The study... Read more
When researchers design a protein expression study, the standard toolkit of IHC, IF, flow cytometry, and other techniques can tell them a great deal about where a protein is and how much of it is... Read more
Organoid research has grown substantially over the past decade and a half. What started with self-organizing intestinal epithelium in basement membrane extract has expanded into a platform used across cancer biology, infectious disease, developmental biology,... Read more
Two Vector scientists were recently interviewed about glycosylation in cancer research and advances in bioconjugation for next-generation therapeutics.
Vector Laboratories will be attending Cancer Glyco-X 2026 to discuss how the right tools reveal glyco-insights in cancer research. Product Manager Shuhui Chen and Sr. Field Application Scientist Sabrina Mateos will be representing Vector Laboratories... Read more
Immune checkpoint therapy describes a class of antibody therapeutics for the treatment of cancer that target proteins that modulate immune responses. More than a dozen approved therapeutics target immune checkpoint proteins like PD-1, PD-L1, and... Read more
Looking Beyond Genes and Proteins Genomics has transformed how we identify disease, and proteomics has expanded how we understand function. But in Congenital Disorders of Glycosylation (CDGs), neither tells the full story. CDGs arise from... Read more
We’re excited to share that Vector Laboratories and VectaPlex™ Antibody Removal Kit were featured in the Biocompare article, “Traditional vs. Multiplex Immunohistochemistry.” The piece highlights the need for multiplexing in tissue analysis and outlines how... Read more
